<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Synbio International Inc. — News on 6ix</title>
<link>https://6ix.com/company/synbio-international-inc</link>
<description>Latest news and press releases for Synbio International Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 08 Apr 2026 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/synbio-international-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c73278dffbe2df11b5af.webp</url>
<title>Synbio International Inc.</title>
<link>https://6ix.com/company/synbio-international-inc</link>
</image>
<item>
<title>Synbio International Secures DWAC and DRS Eligibility</title>
<link>https://6ix.com/company/synbio-international-inc/news/synbio-international-secures-dwac-and-drs-eligibility</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/synbio-international-secures-dwac-and-drs-eligibility</guid>
<pubDate>Wed, 08 Apr 2026 12:30:00 GMT</pubDate>
<description>Synbio International Secures DWAC and DRS Eligibility.</description>
</item>
<item>
<title>Synbio Signs Agreement for a Proof-of-Concept Clinical Trial to Evaluate a Unique AI-Based Facial Analysis Screening Software for Mental Health Disorders</title>
<link>https://6ix.com/company/synbio-international-inc/news/synbio-signs-agreement-proof-concept-130000606</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/synbio-signs-agreement-proof-concept-130000606</guid>
<pubDate>Thu, 15 Jan 2026 13:00:00 GMT</pubDate>
<description>NEW YORK, NY - January 15, 2026 (NEWMEDIAWIRE) - Synbio International Inc. (OTC: SYIN) ("Synbio" or the "Company"), a medical technology company focused on clinically validated AI diagnostics, today announced that it has executed a Master Services Ag...</description>
</item>
<item>
<title>Synbio International Inc. Expands its Board of Directors and Strengthens its Clinical Leadership with the Appointment of Dr. Nick Vatakis</title>
<link>https://6ix.com/company/synbio-international-inc/news/synbio-international-inc-expands-board-130000733</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/synbio-international-inc-expands-board-130000733</guid>
<pubDate>Wed, 22 Oct 2025 13:00:00 GMT</pubDate>
<description>Dr. Vatakis, appointed as Medical Director, brings decades of clinical trial leadership, advancing Synbio’s credibility and the integrity of its upcoming feasibility trialNEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Synbio International Inc. (OTC: SYIN) (“Synbio” or the “Company”) is proud to announce the appointment of Dr. Nick Vatakis, MD as Medical Director. This appointment represents a major milestone in Synbio’s commitment to scientific excellence, clinical rigor, and the successful validat</description>
</item>
<item>
<title>Synbio International Inc. Strengthens Strategic Alliance with FacialDx Inc. through Share Purchase and Warrant Agreements</title>
<link>https://6ix.com/company/synbio-international-inc/news/synbio-international-inc-strengthens-strategic-130000972</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/synbio-international-inc-strengthens-strategic-130000972</guid>
<pubDate>Wed, 08 Oct 2025 13:00:00 GMT</pubDate>
<description>The Share Purchase Agreement (SPA) secures an equity stake in FacialDx and secures ownership in its intellectual property by way of the shareholding.The SPA also enables Synbio to convert future clinical trial expenditures into additional equity in FacialDx at today’s valuation, unlocking substantial upside potential as FaciaDx also scales commercially.A Joint Trial Committee will be established to oversee the design, conduct, and reporting of all clinical studies, maximizing the likelihood of F</description>
</item>
<item>
<title>Synbio International Inc. Expands Board and Strengthens Leadership with Appointment of Chief Financial Officer Ms. Desiree Cain, CPA, MBA</title>
<link>https://6ix.com/company/synbio-international-inc/news/synbio-international-inc-expands-board-140500779</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/synbio-international-inc-expands-board-140500779</guid>
<pubDate>Thu, 02 Oct 2025 14:05:00 GMT</pubDate>
<description>Strategic appointment underscores Synbio’s commitment to financial excellence, governance, and shareholder value NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Synbio International Inc. (OTC: SYIN) (“Synbio” or the “Company”) is pleased to announce the appointment of Ms. Desiree Cain, CPA, MBA as Chief Financial Officer and Member of the Board of Directors, effective immediately. This appointment reflects Synbio’s ongoing commitment to strengthening corporate governance and enhancing financial stra</description>
</item>
<item>
<title>Revolutionizing Mental Health: AI-Powered Facial Screening Technology Set for Clinical Trials</title>
<link>https://6ix.com/company/synbio-international-inc/news/revolutionizing-mental-health-ai-powered-150000153</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/revolutionizing-mental-health-ai-powered-150000153</guid>
<pubDate>Tue, 25 Feb 2025 15:00:00 GMT</pubDate>
<description>Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening). NIMS is a fast, highly accurate and cost-effective method for detecting depressive symptoms through ...</description>
</item>
<item>
<title>Natural Harmony Foods Inc. Completes Financial Audits for 2022 & 2023</title>
<link>https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-completes-financial-audits-for-2022-and-2023</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-completes-financial-audits-for-2022-and-2023</guid>
<pubDate>Thu, 01 Aug 2024 08:24:20 GMT</pubDate>
<description>Natural Harmony Foods Inc. Completes Financial Audits for 2022 & 2023.</description>
</item>
<item>
<title>Reduction of Outstanding Common Stock</title>
<link>https://6ix.com/company/synbio-international-inc/news/reduction-of-outstanding-common-stock</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/reduction-of-outstanding-common-stock</guid>
<pubDate>Tue, 26 Mar 2024 14:03:23 GMT</pubDate>
<description>Reduction of Outstanding Common Stock.</description>
</item>
<item>
<title>Natural Harmony Foods Inc. Changing Name and Logo to Better Reflect Its New Strategic Direction</title>
<link>https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-changing-name-and-logo-to-better-reflect-its-new-strategic-direction</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-changing-name-and-logo-to-better-reflect-its-new-strategic-direction</guid>
<pubDate>Mon, 05 Feb 2024 12:12:10 GMT</pubDate>
<description>Natural Harmony Foods Inc. Changing Name and Logo to Better Reflect Its New Strategic Direction.</description>
</item>
<item>
<title>Natural Harmony Foods Inc. Signs US$5,000,000 Equity Facility to Fund Growth</title>
<link>https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-signs-usdollar5000000-equity-facility-to-fund-growth</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-signs-usdollar5000000-equity-facility-to-fund-growth</guid>
<pubDate>Thu, 16 Nov 2023 14:32:28 GMT</pubDate>
<description>Natural Harmony Foods Inc. Signs US$5,000,000 Equity Facility to Fund Growth.</description>
</item>
<item>
<title>Natural Harmony Foods Inc. Announces New Strategic Direction and Sets the Stage for a Revolution In Healthcare and Wellness</title>
<link>https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-announces-new-strategic-direction-and-sets-the-stage-for-a-revolution-in-healthcare-and-wellness</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-announces-new-strategic-direction-and-sets-the-stage-for-a-revolution-in-healthcare-and-wellness</guid>
<pubDate>Tue, 19 Sep 2023 14:04:06 GMT</pubDate>
<description>Natural Harmony Foods Inc. Announces New Strategic Direction and Sets the Stage for a Revolution In Healthcare and Wellness.</description>
</item>
<item>
<title>Natural Harmony Foods Inc. - Change of Company Control</title>
<link>https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-change-of-company-control</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/natural-harmony-foods-inc-change-of-company-control</guid>
<pubDate>Mon, 11 Sep 2023 13:33:45 GMT</pubDate>
<description>Natural Harmony Foods Inc. - Change of Company Control.</description>
</item>
<item>
<title>SoyLean Now in Publix Supermarkets</title>
<link>https://6ix.com/company/synbio-international-inc/news/soylean-now-in-publix-supermarkets</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/soylean-now-in-publix-supermarkets</guid>
<pubDate>Sat, 15 Oct 2005 16:54:00 GMT</pubDate>
<description>SoyLean Now in Publix Supermarkets.</description>
</item>
<item>
<title>Annual Shareholders Meeting</title>
<link>https://6ix.com/company/synbio-international-inc/news/annual-shareholders-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/synbio-international-inc/news/annual-shareholders-meeting</guid>
<pubDate>Fri, 08 Jul 2005 19:53:00 GMT</pubDate>
<description>Annual Shareholders Meeting.</description>
</item>
</channel>
</rss>